LianBio Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:LIAN.Y Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Nov 23BuyUS$32,195,621Tang Capital Management, LLCCompany7,910,472US$4.07

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of LIAN.Y?
Owner TypeNumber of SharesOwnership Percentage
Institutions161,5210.149%
Individual Insiders1,429,6571.32%
Public Companies5,002,7924.63%
General Public101,571,16093.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 6.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.63%
BridgeBio Pharma, Inc.
5,002,792US$1.5m0%no data
0.92%
Jiuyun Yu
1,000,000US$290.1k0%no data
0.34%
Tassos Anastasios Gianakakos
363,253US$105.4k0%no data
0.14%
Rhumbline Advisers Ltd Partnership
147,721US$42.9k0%no data
0.016%
Susan Silbermann
17,082US$5.0k0%no data
0.016%
Konstantin Poukalov
17,082US$5.0k0%no data
0.016%
Adam Stone
17,082US$5.0k0%no data
0.014%
Jiang Qian
15,158US$4.4k0%no data
0.013%
FNY Investment Advisers, LLC
13,800US$4.0k0%no data